What Happened
Sonam Srivastava of Wright Research states that despite recent corrections, smallcap stocks are not yet 'cheap', advocating for a selective investment strategy. She identifies private banks, pharma, and capital goods as sectors offering opportunities.
Why It Matters (for you)
This analysis is crucial for Indian market participants as it guides investment decisions in the volatile smallcap segment. It suggests that while some froth has cleared, a broad-based rally is unlikely, and stock-picking based on fundamentals and sector strength remains paramount.
Impact on Indian Markets
The advice implies a mixed impact on the broader smallcap index, with potential positive sentiment for specific stocks within private banks (e.g., ICICIBANK, HDFCBANK, AXISBANK), pharma (e.g., SUNPHARMA, DRREDDY, CIPLA), and capital goods (e.g., L&T, SIEMENS). However, it suggests caution for the wider smallcap universe.
What Traders Should Watch Next
Traders should monitor the performance of the identified sectors and specific stocks for signs of sustained momentum. Further corrections in the broader smallcap index could present better entry points, while continued volatility necessitates a balanced asset allocation strategy.
Key Evidence
- Smallcap stocks have corrected sharply but are still not cheap.
- Sonam Srivastava of Wright Research urges investors to stay selective.
- Opportunities highlighted in private banks, pharma, and capital goods.
- Recommends staggered deployment of cash and balanced allocation across equities, gold, silver, and debt.